Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033766
Filing Date
2017-05-18
Accepted
2017-05-18 20:46:34
Documents
1
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4174
  Complete submission text file 0001209191-17-033766.txt   5845
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH SAN FRANCISCO CA 94158
Business Address
Gergel Ivan P. (Reporting) CIK: 0001328288 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 17856254